{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:27:26Z","timestamp":1791192446804,"version":"4.1.0"},"reference-count":43,"publisher":"American Association for Cancer Research (AACR)","issue":"1","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Definition of the molecular pathogenesis of lung cancer allows investigators an enhanced understanding of the natural history of the disease, thus fostering development of new prevention strategies. In addition to regulating epithelial-to-mesenchymal transition (EMT), the transcription factor Snail exerts global effects on gene expression. Our recent studies reveal that Snail is upregulated in non\u2013small cell lung cancer (NSCLC), is associated with poor prognosis, and promotes tumor progression in vivo. Herein, we demonstrate that overexpression of Snail leads to the upregulation of secreted protein, acidic and rich in cysteine (SPARC) in models of premalignancy and established disease, as well as in lung carcinoma tissues in situ. Snail overexpression leads to increased SPARC-dependent invasion in vitro, indicating that SPARC may play a role in lung cancer progression. Bioinformatic analysis implicates transforming growth factor beta (TGF-\u03b2), extracellular signal\u2013regulated kinase (ERK)1\/2, and miR-29b as potential intermediaries in Snail-mediated upregulation of SPARC. Both the TGF-\u03b21 ligand and TGF-\u03b2 receptor 2 (TGF-\u03b2R2) are upregulated following Snail overexpression. Treatment of human bronchial epithelial cell (HBEC) lines with TGF-\u03b21 and inhibition of TGF-\u03b21 mRNA expression modulates SPARC expression. Inhibition of MAP\u2013ERK kinase (MEK) phosphorylation downregulates SPARC. MiR-29b is downregulated in Snail-overexpressing cell lines, whereas overexpression of miR-29b inhibits SPARC expression. In addition, miR-29b is upregulated following ERK inhibition, suggesting a Snail-dependent pathway by which Snail activation of TGF-\u03b2 and ERK signaling results in downregulation of miR-29b and subsequent upregulation of SPARC. Our discovery of pathways responsible for Snail-induced SPARC expression contributes to the definition of NSCLC pathogenesis. Cancer Prev Res; 7(1); 150\u201360. \u00a92013 AACR.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-13-0263","type":"journal-article","created":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T00:17:30Z","timestamp":1384906650000},"page":"150-160","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["A Novel Molecular Pathway for Snail-Dependent, SPARC-Mediated Invasion in Non\u2013Small Cell Lung Cancer Pathogenesis"],"prefix":"10.1158","volume":"7","author":[{"given":"Jeanette L.","family":"Grant","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Pulmonary and Critical Care Medicine, Department of Medicine; Departments of 2Pathology and Laboratory Medicine; and 3Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA; 4Lung Cancer Research Program of The Jonsson Comprehensive Cancer Center, Los Angeles, California; and 5University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Fishbein","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Pulmonary and Critical Care Medicine, Department of Medicine; Departments of 2Pathology and Laboratory Medicine; and 3Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA; 4Lung Cancer Research Program of The Jonsson Comprehensive Cancer Center, Los Angeles, California; and 5University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Sheng","family":"Hong","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Pulmonary and Critical Care Medicine, Department of Medicine; Departments of 2Pathology and Laboratory Medicine; and 3Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA; 4Lung Cancer Research Program of The Jonsson Comprehensive Cancer Center, Los Angeles, California; and 5University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostyantyn","family":"Krysan","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Pulmonary and Critical Care Medicine, Department of Medicine; Departments of 2Pathology and Laboratory Medicine; and 3Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA; 4Lung Cancer Research Program of The Jonsson Comprehensive Cancer Center, Los Angeles, California; and 5University of Texas Southwestern Medical Center, Dallas, Texas"},{"name":"Authors' Affiliations:\u20081Division of Pulmonary and Critical Care Medicine, Department of Medicine; Departments of 2Pathology and Laboratory Medicine; and 3Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA; 4Lung Cancer Research Program of The Jonsson Comprehensive Cancer Center, Los Angeles, California; and 5University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Minna","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Pulmonary and Critical Care Medicine, Department of Medicine; Departments of 2Pathology and Laboratory Medicine; and 3Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA; 4Lung Cancer Research Program of The Jonsson Comprehensive Cancer Center, Los Angeles, California; and 5University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry W.","family":"Shay","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Pulmonary and Critical Care Medicine, Department of Medicine; Departments of 2Pathology and Laboratory Medicine; and 3Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA; 4Lung Cancer Research Program of The Jonsson Comprehensive Cancer Center, Los Angeles, California; and 5University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonya C.","family":"Walser","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Pulmonary and Critical Care Medicine, Department of Medicine; Departments of 2Pathology and Laboratory Medicine; and 3Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA; 4Lung Cancer Research Program of The Jonsson Comprehensive Cancer Center, Los Angeles, California; and 5University of Texas Southwestern Medical Center, Dallas, Texas"},{"name":"Authors' Affiliations:\u20081Division of Pulmonary and Critical Care Medicine, Department of Medicine; Departments of 2Pathology and Laboratory Medicine; and 3Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA; 4Lung Cancer Research Program of The Jonsson Comprehensive Cancer Center, Los Angeles, California; and 5University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Dubinett","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Pulmonary and Critical Care Medicine, Department of Medicine; Departments of 2Pathology and Laboratory Medicine; and 3Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA; 4Lung Cancer Research Program of The Jonsson Comprehensive Cancer Center, Los Angeles, California; and 5University of Texas Southwestern Medical Center, Dallas, Texas"},{"name":"Authors' Affiliations:\u20081Division of Pulmonary and Critical Care Medicine, Department of Medicine; Departments of 2Pathology and Laboratory Medicine; and 3Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA; 4Lung Cancer Research Program of The Jonsson Comprehensive Cancer Center, Los Angeles, California; and 5University of Texas Southwestern Medical Center, Dallas, Texas"},{"name":"Authors' Affiliations:\u20081Division of Pulmonary and Critical Care Medicine, Department of Medicine; Departments of 2Pathology and Laboratory Medicine; and 3Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA; 4Lung Cancer Research Program of The Jonsson Comprehensive Cancer Center, Los Angeles, California; and 5University of Texas Southwestern Medical Center, Dallas, Texas"},{"name":"Authors' Affiliations:\u20081Division of Pulmonary and Critical Care Medicine, Department of Medicine; Departments of 2Pathology and Laboratory Medicine; and 3Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA; 4Lung Cancer Research Program of The Jonsson Comprehensive Cancer Center, Los Angeles, California; and 5University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2014,1,7]]},"reference":[{"key":"2022060816223476300_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"2022060816223476300_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12307-011-0089-0","article-title":"The inflammatory tumor microenvironment, epithelial\u2013mesenchymal transition, and lung carcinogenesis","volume":"5","author":"Heinrich","year":"2012","journal-title":"Cancer Microenviron"},{"key":"2022060816223476300_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MCP.0b013e32832c975a","article-title":"Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer","volume":"15","author":"Lee","year":"2009","journal-title":"Curr Opin Pulm Med"},{"key":"2022060816223476300_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"2022060816223476300_bib5","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1158\/0008-5472.CAN-05-3635","article-title":"Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer","volume":"66","author":"Dohadwala","year":"2006","journal-title":"Cancer Res"},{"key":"2022060816223476300_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1074\/jbc.M804777200","article-title":"Role of Ras signaling in the induction of snail by transforming growth factor-beta","volume":"284","author":"Horiguchi","year":"2009","journal-title":"J Biol Chem"},{"key":"2022060816223476300_bib7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/MCB.24.1.306-319.2004","article-title":"Snail mediates E-cadherin repression by the recruitment of the Sin3A\/histone deacetylase 1 (HDAC1)\/HDAC2 complex","volume":"24","author":"Peinado","year":"2004","journal-title":"Mol Cell Biol"},{"key":"2022060816223476300_bib8","doi-asserted-by":"crossref","first-page":"21113","DOI":"10.1074\/jbc.M211304200","article-title":"Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial\u2013mesenchymal transitions","volume":"278","author":"Peinado","year":"2003","journal-title":"J Biol Chem"},{"key":"2022060816223476300_bib9","doi-asserted-by":"crossref","first-page":"e26514","DOI":"10.1371\/journal.pone.0026514","article-title":"The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer","volume":"6","author":"Dhasarathy","year":"2011","journal-title":"PLoS ONE"},{"key":"2022060816223476300_bib10","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1158\/1541-7786.MCR-11-0271","article-title":"IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway","volume":"9","author":"Yadav","year":"2011","journal-title":"Mol Cancer Res"},{"key":"2022060816223476300_bib11","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4161\/cbt.12.8.15981","article-title":"Snail as a key regulator of PRL-3 gene in colorectal cancer","volume":"12","author":"Zheng","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"2022060816223476300_bib12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"2022060816223476300_bib13","doi-asserted-by":"crossref","first-page":"e58915","DOI":"10.1371\/journal.pone.0058915","article-title":"P38\/NF-kappaB\/Snail pathway is involved in caffeic acid-induced inhibition of cancer stem cells\u2013like properties and migratory capacity in malignant human keratinocyte","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS ONE"},{"key":"2022060816223476300_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/pin.12018","article-title":"Morphophenotype of floating colonies derived from a single cancer cell has a critical impact on tumor-forming activity","volume":"63","author":"Ishii","year":"2013","journal-title":"Pathol Int"},{"key":"2022060816223476300_bib15","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1158\/1078-0432.CCR-09-1558","article-title":"Snail promotes CXCR2 ligand-dependent tumor progression in non\u2013small cell lung carcinoma","volume":"15","author":"Yanagawa","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2022060816223476300_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0092-8674(81)90037-4","article-title":"Osteonectin, a bone-specific protein linking mineral to collagen","volume":"26","author":"Termine","year":"1981","journal-title":"Cell"},{"key":"2022060816223476300_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1096\/fasebj.8.2.8119487","article-title":"The biology of SPARC, a protein that modulates cell-matrix interactions","volume":"8","author":"Lane","year":"1994","journal-title":"FASEB J"},{"key":"2022060816223476300_bib18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/jcb.20091","article-title":"SPARC and tumor growth: where the seed meets the soil?","volume":"92","author":"Framson","year":"2004","journal-title":"J Cell Biochem"},{"key":"2022060816223476300_bib19","first-page":"5376","article-title":"Enhanced expression of SPARC\/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia\/acidity and with poor prognosis of patients","volume":"63","author":"Koukourakis","year":"2003","journal-title":"Cancer Res"},{"key":"2022060816223476300_bib20","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1158\/1541-7786.MCR-12-0634-T","article-title":"Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations","volume":"11","author":"Sato","year":"2013","journal-title":"Mol Cancer Res"},{"key":"2022060816223476300_bib21","doi-asserted-by":"crossref","first-page":"9027","DOI":"10.1158\/0008-5472.CAN-04-3703","article-title":"Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins","volume":"64","author":"Ramirez","year":"2004","journal-title":"Cancer Res"},{"key":"2022060816223476300_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1432-0436.2006.00069.x","article-title":"A three-dimensional model of differentiation of immortalized human bronchial epithelial cells","volume":"74","author":"Vaughan","year":"2006","journal-title":"Differentiation"},{"key":"2022060816223476300_bib23","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1097\/01.JTO.0000282957.22684.90","article-title":"Molecular pathogenesis of lung cancer with translation to the clinic","volume":"2","author":"Minna","year":"2007","journal-title":"J Thorac Oncol"},{"key":"2022060816223476300_bib24","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1172\/JCI32526","article-title":"Squamous metaplasia amplifies pathologic epithelial\u2013mesenchymal interactions in COPD patients","volume":"117","author":"Araya","year":"2007","journal-title":"J Clin Invest"},{"key":"2022060816223476300_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.plefa.2007.05.006","article-title":"Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non\u2013small cell lung cancer cells","volume":"77","author":"Hazra","year":"2007","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2022060816223476300_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2022060816223476300_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1073\/pnas.98.1.31","article-title":"Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection","volume":"98","author":"Li","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060816223476300_bib28","doi-asserted-by":"crossref","first-page":"11721","DOI":"10.1158\/0008-5472.CAN-07-2318","article-title":"SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells","volume":"67","author":"Olmeda","year":"2007","journal-title":"Cancer Res"},{"key":"2022060816223476300_bib29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.molcel.2010.02.020","article-title":"ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events","volume":"38","author":"Shin","year":"2010","journal-title":"Mol Cell"},{"key":"2022060816223476300_bib30","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.1158\/0008-5472.CAN-10-2034","article-title":"Persistent activation of the Fyn\/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARC","volume":"70","author":"Fenouille","year":"2010","journal-title":"Cancer Res"},{"key":"2022060816223476300_bib31","doi-asserted-by":"crossref","first-page":"10495","DOI":"10.1074\/jbc.M110.195628","article-title":"Pancreatic cancer cells respond to type I collagen by inducing snail expression to promote membrane type 1 matrix metalloproteinase-dependent collagen invasion","volume":"286","author":"Shields","year":"2011","journal-title":"J Biol Chem"},{"key":"2022060816223476300_bib32","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.bjc.6601644","article-title":"ERK1\/2 is activated in non\u2013small cell lung cancer and associated with advanced tumours","volume":"90","author":"Vicent","year":"2004","journal-title":"Br J Cancer"},{"key":"2022060816223476300_bib33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-6-56","article-title":"TGF-beta1 induces human alveolar epithelial-to-mesenchymal cell transition (EMT)","volume":"6","author":"Kasai","year":"2005","journal-title":"Respir Res"},{"key":"2022060816223476300_bib34","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1096\/fj.03-0037fje","article-title":"Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells","volume":"17","author":"Hayashida","year":"2003","journal-title":"FASEB J"},{"key":"2022060816223476300_bib35","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/cncr.24133","article-title":"Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer","volume":"115","author":"Varlotto","year":"2009","journal-title":"Cancer"},{"key":"2022060816223476300_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMcibr0808031","article-title":"The crossroads of oncogenesis and metastasis","volume":"360","author":"Sanchez-Garcia","year":"2009","journal-title":"N Engl J Med"},{"key":"2022060816223476300_bib37","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1378\/chest.12-0710","article-title":"Identification of stage I non\u2013small cell lung cancer patients at high risk for local recurrence following sublobar resection","volume":"143","author":"Varlotto","year":"2013","journal-title":"Chest"},{"key":"2022060816223476300_bib38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","article-title":"Systemic spread is an early step in breast cancer","volume":"13","author":"Husemann","year":"2008","journal-title":"Cancer Cell"},{"key":"2022060816223476300_bib39","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1126\/science.1161621","article-title":"Seeding and propagation of untransformed mouse mammary cells in the lung","volume":"321","author":"Podsypanina","year":"2008","journal-title":"Science"},{"key":"2022060816223476300_bib40","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s00259-010-1505-2","article-title":"The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours","volume":"37","author":"Dijkman","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2022060816223476300_bib41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1083\/jcb.201302132","article-title":"Distinct signaling mechanisms regulate migration in unconfined versus confined spaces","volume":"202","author":"Hung","year":"2013","journal-title":"J Cell Biol"},{"key":"2022060816223476300_bib42","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1158\/0008-5472.CAN-05-3189","article-title":"SPARC represses E-cadherin and induces mesenchymal transition during melanoma development","volume":"66","author":"Robert","year":"2006","journal-title":"Cancer Res"},{"key":"2022060816223476300_bib43","doi-asserted-by":"crossref","first-page":"G739","DOI":"10.1152\/ajpgi.00316.2010","article-title":"SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-beta1 and PDGF","volume":"300","author":"Atorrasagasti","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/7\/1\/150\/2252890\/150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/7\/1\/150\/2252890\/150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T14:26:48Z","timestamp":1654698408000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/7\/1\/150\/50242\/A-Novel-Molecular-Pathway-for-Snail-Dependent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,7]]},"published-print":{"date-parts":[[2014,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-13-0263","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.c.6544754","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22525448.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6544754.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22525448","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,1]]}}}